Alessio Cantore

Alessio Cantore has a Ph.D. in cellular and molecular biology and is currently Group Leader at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) and Assistant Professor of Tissue Biology at the San Raffaele University, Milan, Italy. His research interests span between lentiviral vector engineering, liver biology and the translational applications of liver-directed gene therapy. He has made seminal contributions to the field of liver-directed gene therapy by evaluating the efficacy and safety of systemic lentiviral vector administration in different experimental models and engineering vectors with enhanced biological properties, reduced immunogenicity and high potency. He has published 12 original research articles and 3 review articles on peer-reviewed international scientific journals (h-index: 11), is inventor of 5 patents, has been invited to speak at several international conferences and is recipient of the 2018 Young Investigator Award, from the European Society of Gene and Cell Therapy.